The global average selling price for true wireless earbuds declined from roughly USD 100 in 2022 to USD 65 in 2025. Over-ear Bluetooth headphones saw an average selling price decline from USD 155 to USD 128 over the same period because of promotional retail cycles and online-only brands. By contrast, Bluetooth hearing aids and medical audio devices have remained in a more stable price corridor, with over-the-counter device prices around USD 299-999 per pair and prescription-grade devices above USD 1,500.
A typical USD 149 premium true wireless earbud has a bill-of-materials cost near USD 55, broken down as: USD 15 for the Bluetooth Low Energy SoC and RF front end, USD 12 for acoustic drivers and microphones, USD 9 for battery and charging case, USD 8 for enclosure, USD 6 for assembly and testing, and USD 5 for software, codecs, and certification. Distribution and marketing add another USD 45-55, leaving a manufacturer operating margin of 15-25% before tax. Value migrates upward to brands with proprietary sensor fusion, codecs, and channel pricing control.
For Bluetooth medical wearables, cost structure is inverted. Regulatory testing, clinical evidence, and post-market surveillance account for 30-45% of initial product cost, while electronics are a smaller share. This structure generates gross margins of 55-70% for approved devices, and it explains why consumer technology firms are seeking over-the-counter hearing-aid approvals rather than building unregulated devices with no reimbursement or clinical value.
Component raw materials are less differentiated than in prior decades. NAND flash, battery cells, and MEMS microphones follow commodity pricing cycles, but high-end DSP memory bandwidth and Bluetooth qualification costs create an entry threshold. Vendors with scale and vertical integration, such as Apple, Samsung, and Huawei, can absorb semiconductor price increases more easily than mid-tier Chinese OEMs, which pass cost pressure directly to final prices.